Company intelligence / Profile preview

Helaxa

Berlin, Berlin, Germanyhelaxa.com ↗

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Helaxa is a new but rapidly growing German manufacturer specializing in the production of heparin, a life-saving anticoagulant active pharmaceutical ingredient. The company aims to strengthen European supply chains for heparin with large-scale, state-of-the-art manufacturing facilities and robust pan-European partnerships. Their mission centers on ensuring security of supply for this essential medicine by building independence from non-European sources and fostering fair, transparent business relationships.

Therapeutic areas: HematologyCardiovascular
Modalities: Small moleculeBiologic
Industry: Contract Manufacturing Organization

Partnerships

Strong pan-European supply chain partners in pharma manufacturing and distribution are referenced but not named specifically.

Beyond the preview

Go deeper on Helaxa.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Helaxa.

Explore the full profile